nodes	percent_of_prediction	percent_of_DWPC	metapath
Zonisamide—CACNA1G—Nicotine Activity on Chromaffin Cells—CHRNB4—nicotine dependence	0.044	0.289	CbGpPWpGaD
Zonisamide—Bradyphrenia—Varenicline—nicotine dependence	0.0388	0.0752	CcSEcCtD
Zonisamide—CA6—saliva—nicotine dependence	0.036	0.108	CbGeAlD
Zonisamide—CACNA1G—Nicotine Activity on Chromaffin Cells—CHRNA3—nicotine dependence	0.0333	0.219	CbGpPWpGaD
Zonisamide—SCN2B—cardiovascular system—nicotine dependence	0.0184	0.0555	CbGeAlD
Zonisamide—SCN1B—cardiovascular system—nicotine dependence	0.0167	0.0502	CbGeAlD
Zonisamide—Facial paralysis—Varenicline—nicotine dependence	0.0165	0.032	CcSEcCtD
Zonisamide—CA8—cardiovascular system—nicotine dependence	0.0157	0.0472	CbGeAlD
Zonisamide—Anger—Varenicline—nicotine dependence	0.0147	0.0285	CcSEcCtD
Zonisamide—SCN2B—midbrain—nicotine dependence	0.0144	0.0434	CbGeAlD
Zonisamide—VIIth nerve paralysis—Varenicline—nicotine dependence	0.0128	0.0248	CcSEcCtD
Zonisamide—CA10—midbrain—nicotine dependence	0.0125	0.0376	CbGeAlD
Zonisamide—SCN3B—midbrain—nicotine dependence	0.012	0.0362	CbGeAlD
Zonisamide—Pancreatitis acute—Varenicline—nicotine dependence	0.0114	0.022	CcSEcCtD
Zonisamide—SCN4B—midbrain—nicotine dependence	0.0102	0.0308	CbGeAlD
Zonisamide—Urine abnormality—Varenicline—nicotine dependence	0.00949	0.0184	CcSEcCtD
Zonisamide—Suicide attempt—Varenicline—nicotine dependence	0.00926	0.0179	CcSEcCtD
Zonisamide—SCN2B—brain—nicotine dependence	0.00904	0.0272	CbGeAlD
Zonisamide—Urine analysis abnormal—Varenicline—nicotine dependence	0.00894	0.0173	CcSEcCtD
Zonisamide—CA11—midbrain—nicotine dependence	0.00879	0.0265	CbGeAlD
Zonisamide—SCN1B—brain—nicotine dependence	0.00818	0.0246	CbGeAlD
Zonisamide—Parosmia—Varenicline—nicotine dependence	0.0081	0.0157	CcSEcCtD
Zonisamide—CA10—brain—nicotine dependence	0.00784	0.0236	CbGeAlD
Zonisamide—CA8—brain—nicotine dependence	0.00769	0.0232	CbGeAlD
Zonisamide—Haematemesis—Varenicline—nicotine dependence	0.00756	0.0147	CcSEcCtD
Zonisamide—SCN3B—brain—nicotine dependence	0.00755	0.0227	CbGeAlD
Zonisamide—Suicidal ideation—Varenicline—nicotine dependence	0.00749	0.0145	CcSEcCtD
Zonisamide—Nystagmus—Varenicline—nicotine dependence	0.00736	0.0142	CcSEcCtD
Zonisamide—Menorrhagia—Varenicline—nicotine dependence	0.0071	0.0138	CcSEcCtD
Zonisamide—Scotoma—Varenicline—nicotine dependence	0.00692	0.0134	CcSEcCtD
Zonisamide—CA3—cardiovascular system—nicotine dependence	0.00687	0.0207	CbGeAlD
Zonisamide—Gingivitis—Varenicline—nicotine dependence	0.00669	0.013	CcSEcCtD
Zonisamide—CA13—brain—nicotine dependence	0.00658	0.0198	CbGeAlD
Zonisamide—Nephrolithiasis—Varenicline—nicotine dependence	0.00654	0.0127	CcSEcCtD
Zonisamide—SCN4B—brain—nicotine dependence	0.00642	0.0193	CbGeAlD
Zonisamide—SCN4B—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00634	0.0417	CbGpPWpGaD
Zonisamide—CACNA1I—brain—nicotine dependence	0.00627	0.0189	CbGeAlD
Zonisamide—Disturbance in attention—Varenicline—nicotine dependence	0.00607	0.0117	CcSEcCtD
Zonisamide—Aggression—Varenicline—nicotine dependence	0.00598	0.0116	CcSEcCtD
Zonisamide—Accidental injury—Varenicline—nicotine dependence	0.00594	0.0115	CcSEcCtD
Zonisamide—SCN3B—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00589	0.0388	CbGpPWpGaD
Zonisamide—CA7—midbrain—nicotine dependence	0.00585	0.0176	CbGeAlD
Zonisamide—Ventricular extrasystoles—Varenicline—nicotine dependence	0.00582	0.0113	CcSEcCtD
Zonisamide—CACNA1H—cardiovascular system—nicotine dependence	0.00573	0.0173	CbGeAlD
Zonisamide—Nocturia—Varenicline—nicotine dependence	0.00566	0.011	CcSEcCtD
Zonisamide—Leukocytosis—Varenicline—nicotine dependence	0.00559	0.0108	CcSEcCtD
Zonisamide—Dysarthria—Varenicline—nicotine dependence	0.00556	0.0108	CcSEcCtD
Zonisamide—CA11—brain—nicotine dependence	0.00552	0.0166	CbGeAlD
Zonisamide—Coordination abnormal—Varenicline—nicotine dependence	0.00535	0.0104	CcSEcCtD
Zonisamide—Pulmonary embolism—Varenicline—nicotine dependence	0.00525	0.0102	CcSEcCtD
Zonisamide—Abnormal dreams—Varenicline—nicotine dependence	0.00519	0.0101	CcSEcCtD
Zonisamide—Influenza like illness—Varenicline—nicotine dependence	0.0051	0.00989	CcSEcCtD
Zonisamide—Photophobia—Varenicline—nicotine dependence	0.00493	0.00956	CcSEcCtD
Zonisamide—CA14—midbrain—nicotine dependence	0.00487	0.0147	CbGeAlD
Zonisamide—Oesophagitis—Varenicline—nicotine dependence	0.0048	0.0093	CcSEcCtD
Zonisamide—SCN9A—midbrain—nicotine dependence	0.00477	0.0144	CbGeAlD
Zonisamide—Mouth ulceration—Varenicline—nicotine dependence	0.00475	0.0092	CcSEcCtD
Zonisamide—Urine output increased—Varenicline—nicotine dependence	0.00475	0.0092	CcSEcCtD
Zonisamide—Hypertonia—Varenicline—nicotine dependence	0.00461	0.00892	CcSEcCtD
Zonisamide—Euphoric mood—Varenicline—nicotine dependence	0.00451	0.00875	CcSEcCtD
Zonisamide—SCN11A—brain—nicotine dependence	0.0045	0.0136	CbGeAlD
Zonisamide—Lymphadenopathy—Varenicline—nicotine dependence	0.00447	0.00866	CcSEcCtD
Zonisamide—CA5B—cardiovascular system—nicotine dependence	0.00436	0.0131	CbGeAlD
Zonisamide—Polyuria—Varenicline—nicotine dependence	0.00434	0.00841	CcSEcCtD
Zonisamide—CACNA1G—brain—nicotine dependence	0.0043	0.0129	CbGeAlD
Zonisamide—Deafness—Varenicline—nicotine dependence	0.00426	0.00826	CcSEcCtD
Zonisamide—Eczema—Varenicline—nicotine dependence	0.00424	0.00822	CcSEcCtD
Zonisamide—SCN5A—cardiovascular system—nicotine dependence	0.00423	0.0127	CbGeAlD
Zonisamide—SCN4B—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00423	0.0278	CbGpPWpGaD
Zonisamide—Injury—Varenicline—nicotine dependence	0.00415	0.00804	CcSEcCtD
Zonisamide—Libido decreased—Varenicline—nicotine dependence	0.00411	0.00797	CcSEcCtD
Zonisamide—SCN1A—midbrain—nicotine dependence	0.00411	0.0124	CbGeAlD
Zonisamide—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00409	0.027	CbGpPWpGaD
Zonisamide—Amnesia—Varenicline—nicotine dependence	0.00406	0.00786	CcSEcCtD
Zonisamide—Atrial fibrillation—Varenicline—nicotine dependence	0.00403	0.0078	CcSEcCtD
Zonisamide—Thirst—Varenicline—nicotine dependence	0.00401	0.00776	CcSEcCtD
Zonisamide—SCN3B—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00393	0.0259	CbGpPWpGaD
Zonisamide—Arthritis—Varenicline—nicotine dependence	0.00392	0.0076	CcSEcCtD
Zonisamide—Hypoglycaemia—Varenicline—nicotine dependence	0.00391	0.00757	CcSEcCtD
Zonisamide—Cerebrovascular accident—Varenicline—nicotine dependence	0.00389	0.00754	CcSEcCtD
Zonisamide—CA1—cardiovascular system—nicotine dependence	0.00385	0.0116	CbGeAlD
Zonisamide—SCN4B—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00384	0.0253	CbGpPWpGaD
Zonisamide—Osteoarthritis—Varenicline—nicotine dependence	0.00381	0.00739	CcSEcCtD
Zonisamide—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.00378	0.00733	CcSEcCtD
Zonisamide—SCN2A—midbrain—nicotine dependence	0.00377	0.0114	CbGeAlD
Zonisamide—Affect lability—Varenicline—nicotine dependence	0.00375	0.00727	CcSEcCtD
Zonisamide—Psychotic disorder—Varenicline—nicotine dependence	0.00373	0.00722	CcSEcCtD
Zonisamide—CA7—brain—nicotine dependence	0.00367	0.0111	CbGeAlD
Zonisamide—Irritability—Varenicline—nicotine dependence	0.00364	0.00705	CcSEcCtD
Zonisamide—Urinary retention—Varenicline—nicotine dependence	0.00363	0.00703	CcSEcCtD
Zonisamide—Mood swings—Varenicline—nicotine dependence	0.00361	0.007	CcSEcCtD
Zonisamide—SCN3B—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00357	0.0235	CbGpPWpGaD
Zonisamide—Liver function test abnormal—Varenicline—nicotine dependence	0.00352	0.00682	CcSEcCtD
Zonisamide—Dry skin—Varenicline—nicotine dependence	0.0035	0.00677	CcSEcCtD
Zonisamide—Hypokalaemia—Varenicline—nicotine dependence	0.00347	0.00672	CcSEcCtD
Zonisamide—Gastritis—Varenicline—nicotine dependence	0.00338	0.00654	CcSEcCtD
Zonisamide—CA3—brain—nicotine dependence	0.00337	0.0102	CbGeAlD
Zonisamide—SCN3A—midbrain—nicotine dependence	0.00331	0.00998	CbGeAlD
Zonisamide—Dysphagia—Varenicline—nicotine dependence	0.0033	0.00639	CcSEcCtD
Zonisamide—MAOB—cardiovascular system—nicotine dependence	0.00313	0.00942	CbGeAlD
Zonisamide—CA14—brain—nicotine dependence	0.00306	0.00922	CbGeAlD
Zonisamide—Pollakiuria—Varenicline—nicotine dependence	0.00305	0.0059	CcSEcCtD
Zonisamide—Erectile dysfunction—Varenicline—nicotine dependence	0.00304	0.00588	CcSEcCtD
Zonisamide—CA4—cardiovascular system—nicotine dependence	0.00301	0.00908	CbGeAlD
Zonisamide—Weight increased—Varenicline—nicotine dependence	0.003	0.00581	CcSEcCtD
Zonisamide—SCN9A—brain—nicotine dependence	0.003	0.00904	CbGeAlD
Zonisamide—Depression—Varenicline—nicotine dependence	0.00293	0.00568	CcSEcCtD
Zonisamide—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00291	0.00565	CcSEcCtD
Zonisamide—MAOB—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00288	0.0189	CbGpPWpGaD
Zonisamide—Stomatitis—Varenicline—nicotine dependence	0.00287	0.00555	CcSEcCtD
Zonisamide—Conjunctivitis—Varenicline—nicotine dependence	0.00286	0.00553	CcSEcCtD
Zonisamide—CACNA1H—brain—nicotine dependence	0.00281	0.00847	CbGeAlD
Zonisamide—Hepatobiliary disease—Varenicline—nicotine dependence	0.00278	0.00539	CcSEcCtD
Zonisamide—Bradycardia—Varenicline—nicotine dependence	0.00269	0.0052	CcSEcCtD
Zonisamide—SCN4A—brain—nicotine dependence	0.00268	0.00806	CbGeAlD
Zonisamide—MAOA—cardiovascular system—nicotine dependence	0.00267	0.00804	CbGeAlD
Zonisamide—Hallucination—Varenicline—nicotine dependence	0.00263	0.00509	CcSEcCtD
Zonisamide—Urinary tract disorder—Varenicline—nicotine dependence	0.00261	0.00505	CcSEcCtD
Zonisamide—Oedema peripheral—Varenicline—nicotine dependence	0.0026	0.00504	CcSEcCtD
Zonisamide—Connective tissue disorder—Varenicline—nicotine dependence	0.00259	0.00502	CcSEcCtD
Zonisamide—Urethral disorder—Varenicline—nicotine dependence	0.00259	0.00501	CcSEcCtD
Zonisamide—SCN1A—brain—nicotine dependence	0.00258	0.00777	CbGeAlD
Zonisamide—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.00254	0.0167	CbGpPWpGaD
Zonisamide—CA2—cardiovascular system—nicotine dependence	0.0025	0.00753	CbGeAlD
Zonisamide—Erythema multiforme—Varenicline—nicotine dependence	0.00249	0.00483	CcSEcCtD
Zonisamide—Eye disorder—Varenicline—nicotine dependence	0.00247	0.00478	CcSEcCtD
Zonisamide—Tinnitus—Varenicline—nicotine dependence	0.00246	0.00477	CcSEcCtD
Zonisamide—MAOB—midbrain—nicotine dependence	0.00244	0.00736	CbGeAlD
Zonisamide—CA12—brain—nicotine dependence	0.00239	0.00719	CbGeAlD
Zonisamide—Immune system disorder—Varenicline—nicotine dependence	0.00238	0.00462	CcSEcCtD
Zonisamide—Mediastinal disorder—Varenicline—nicotine dependence	0.00238	0.00461	CcSEcCtD
Zonisamide—SCN2A—brain—nicotine dependence	0.00237	0.00713	CbGeAlD
Zonisamide—CA4—midbrain—nicotine dependence	0.00235	0.00709	CbGeAlD
Zonisamide—Mental disorder—Varenicline—nicotine dependence	0.00231	0.00448	CcSEcCtD
Zonisamide—Malnutrition—Varenicline—nicotine dependence	0.0023	0.00445	CcSEcCtD
Zonisamide—Flatulence—Varenicline—nicotine dependence	0.00226	0.00438	CcSEcCtD
Zonisamide—Dysgeusia—Varenicline—nicotine dependence	0.00225	0.00436	CcSEcCtD
Zonisamide—Muscle spasms—Varenicline—nicotine dependence	0.00221	0.00428	CcSEcCtD
Zonisamide—Tremor—Varenicline—nicotine dependence	0.00215	0.00417	CcSEcCtD
Zonisamide—CA5B—brain—nicotine dependence	0.00214	0.00645	CbGeAlD
Zonisamide—Ill-defined disorder—Varenicline—nicotine dependence	0.00213	0.00413	CcSEcCtD
Zonisamide—Anaemia—Varenicline—nicotine dependence	0.00212	0.00411	CcSEcCtD
Zonisamide—Agitation—Varenicline—nicotine dependence	0.00211	0.00409	CcSEcCtD
Zonisamide—MAOA—midbrain—nicotine dependence	0.00208	0.00628	CbGeAlD
Zonisamide—SCN3A—brain—nicotine dependence	0.00208	0.00627	CbGeAlD
Zonisamide—SCN5A—brain—nicotine dependence	0.00207	0.00625	CbGeAlD
Zonisamide—Malaise—Varenicline—nicotine dependence	0.00207	0.00401	CcSEcCtD
Zonisamide—Vertigo—Varenicline—nicotine dependence	0.00206	0.004	CcSEcCtD
Zonisamide—Syncope—Varenicline—nicotine dependence	0.00206	0.00399	CcSEcCtD
Zonisamide—Palpitations—Varenicline—nicotine dependence	0.00203	0.00393	CcSEcCtD
Zonisamide—Loss of consciousness—Varenicline—nicotine dependence	0.00202	0.00391	CcSEcCtD
Zonisamide—Cough—Varenicline—nicotine dependence	0.002	0.00388	CcSEcCtD
Zonisamide—AOX1—brain—nicotine dependence	0.00199	0.006	CbGeAlD
Zonisamide—Convulsion—Varenicline—nicotine dependence	0.00199	0.00386	CcSEcCtD
Zonisamide—Hypertension—Varenicline—nicotine dependence	0.00198	0.00384	CcSEcCtD
Zonisamide—Arthralgia—Varenicline—nicotine dependence	0.00196	0.00379	CcSEcCtD
Zonisamide—Chest pain—Varenicline—nicotine dependence	0.00196	0.00379	CcSEcCtD
Zonisamide—Myalgia—Varenicline—nicotine dependence	0.00196	0.00379	CcSEcCtD
Zonisamide—CA2—midbrain—nicotine dependence	0.00195	0.00588	CbGeAlD
Zonisamide—Anxiety—Varenicline—nicotine dependence	0.00195	0.00378	CcSEcCtD
Zonisamide—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00194	0.00376	CcSEcCtD
Zonisamide—Discomfort—Varenicline—nicotine dependence	0.00193	0.00374	CcSEcCtD
Zonisamide—Dry mouth—Varenicline—nicotine dependence	0.00191	0.0037	CcSEcCtD
Zonisamide—CA1—brain—nicotine dependence	0.00189	0.0057	CbGeAlD
Zonisamide—Oedema—Varenicline—nicotine dependence	0.00187	0.00363	CcSEcCtD
Zonisamide—Infection—Varenicline—nicotine dependence	0.00186	0.00361	CcSEcCtD
Zonisamide—Shock—Varenicline—nicotine dependence	0.00184	0.00357	CcSEcCtD
Zonisamide—Nervous system disorder—Varenicline—nicotine dependence	0.00184	0.00356	CcSEcCtD
Zonisamide—Thrombocytopenia—Varenicline—nicotine dependence	0.00184	0.00356	CcSEcCtD
Zonisamide—Tachycardia—Varenicline—nicotine dependence	0.00183	0.00354	CcSEcCtD
Zonisamide—Skin disorder—Varenicline—nicotine dependence	0.00182	0.00353	CcSEcCtD
Zonisamide—Hyperhidrosis—Varenicline—nicotine dependence	0.00181	0.00351	CcSEcCtD
Zonisamide—MAOA—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00181	0.0119	CbGpPWpGaD
Zonisamide—Anorexia—Varenicline—nicotine dependence	0.00179	0.00346	CcSEcCtD
Zonisamide—Hypotension—Varenicline—nicotine dependence	0.00175	0.00339	CcSEcCtD
Zonisamide—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00171	0.00331	CcSEcCtD
Zonisamide—Insomnia—Varenicline—nicotine dependence	0.0017	0.00328	CcSEcCtD
Zonisamide—Dyspnoea—Varenicline—nicotine dependence	0.00167	0.00324	CcSEcCtD
Zonisamide—Somnolence—Varenicline—nicotine dependence	0.00167	0.00323	CcSEcCtD
Zonisamide—Dyspepsia—Varenicline—nicotine dependence	0.00165	0.0032	CcSEcCtD
Zonisamide—Decreased appetite—Varenicline—nicotine dependence	0.00163	0.00316	CcSEcCtD
Zonisamide—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00162	0.00314	CcSEcCtD
Zonisamide—Fatigue—Varenicline—nicotine dependence	0.00162	0.00313	CcSEcCtD
Zonisamide—Constipation—Varenicline—nicotine dependence	0.0016	0.00311	CcSEcCtD
Zonisamide—Feeling abnormal—Varenicline—nicotine dependence	0.00154	0.00299	CcSEcCtD
Zonisamide—MAOB—brain—nicotine dependence	0.00153	0.00462	CbGeAlD
Zonisamide—Gastrointestinal pain—Varenicline—nicotine dependence	0.00153	0.00297	CcSEcCtD
Zonisamide—MAOB—Biological oxidations—CYP2A7—nicotine dependence	0.00153	0.0101	CbGpPWpGaD
Zonisamide—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00153	0.01	CbGpPWpGaD
Zonisamide—CA13—Metabolism—CYP2A7—nicotine dependence	0.00151	0.00993	CbGpPWpGaD
Zonisamide—Urticaria—Varenicline—nicotine dependence	0.00149	0.00288	CcSEcCtD
Zonisamide—Body temperature increased—Varenicline—nicotine dependence	0.00148	0.00287	CcSEcCtD
Zonisamide—Abdominal pain—Varenicline—nicotine dependence	0.00148	0.00287	CcSEcCtD
Zonisamide—CA4—brain—nicotine dependence	0.00148	0.00445	CbGeAlD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00139	0.00915	CbGpPWpGaD
Zonisamide—Hypersensitivity—Varenicline—nicotine dependence	0.00138	0.00268	CcSEcCtD
Zonisamide—Asthenia—Varenicline—nicotine dependence	0.00135	0.00261	CcSEcCtD
Zonisamide—Pruritus—Varenicline—nicotine dependence	0.00133	0.00257	CcSEcCtD
Zonisamide—MAOA—brain—nicotine dependence	0.00131	0.00394	CbGeAlD
Zonisamide—Diarrhoea—Varenicline—nicotine dependence	0.00128	0.00248	CcSEcCtD
Zonisamide—MAOA—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00124	0.00816	CbGpPWpGaD
Zonisamide—Dizziness—Varenicline—nicotine dependence	0.00124	0.0024	CcSEcCtD
Zonisamide—CA2—brain—nicotine dependence	0.00123	0.00369	CbGeAlD
Zonisamide—Vomiting—Varenicline—nicotine dependence	0.00119	0.00231	CcSEcCtD
Zonisamide—Rash—Varenicline—nicotine dependence	0.00118	0.00229	CcSEcCtD
Zonisamide—Dermatitis—Varenicline—nicotine dependence	0.00118	0.00229	CcSEcCtD
Zonisamide—MAOA—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00118	0.00774	CbGpPWpGaD
Zonisamide—Headache—Varenicline—nicotine dependence	0.00117	0.00228	CcSEcCtD
Zonisamide—Nausea—Varenicline—nicotine dependence	0.00111	0.00216	CcSEcCtD
Zonisamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00105	0.00694	CbGpPWpGaD
Zonisamide—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00104	0.00685	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.000994	0.00654	CbGpPWpGaD
Zonisamide—MAOA—Biological oxidations—CYP2A7—nicotine dependence	0.000959	0.00631	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—CHRNB3—nicotine dependence	0.00095	0.00625	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000927	0.0061	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—CHRNA6—nicotine dependence	0.000901	0.00593	CbGpPWpGaD
Zonisamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000854	0.00562	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00085	0.00559	CbGpPWpGaD
Zonisamide—SCN5A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000842	0.00554	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.000815	0.00536	CbGpPWpGaD
Zonisamide—CA3—Metabolism—CYP2A7—nicotine dependence	0.000792	0.00522	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.000757	0.00499	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.000663	0.00437	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—GABRA4—nicotine dependence	0.000651	0.00429	CbGpPWpGaD
Zonisamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000634	0.00417	CbGpPWpGaD
Zonisamide—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000625	0.00412	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—CHRNB4—nicotine dependence	0.000624	0.00411	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.000617	0.00407	CbGpPWpGaD
Zonisamide—MAOA—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.000602	0.00396	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—CHRNA5—nicotine dependence	0.00058	0.00382	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.000544	0.00358	CbGpPWpGaD
Zonisamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000514	0.00338	CbGpPWpGaD
Zonisamide—CA14—Metabolism—CYP2A7—nicotine dependence	0.00051	0.00336	CbGpPWpGaD
Zonisamide—CA5A—Metabolism—CYP2A7—nicotine dependence	0.000497	0.00328	CbGpPWpGaD
Zonisamide—CA6—Metabolism—CYP2A7—nicotine dependence	0.000497	0.00328	CbGpPWpGaD
Zonisamide—MAOA—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000494	0.00325	CbGpPWpGaD
Zonisamide—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000481	0.00317	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—CHRNA3—nicotine dependence	0.000473	0.00311	CbGpPWpGaD
Zonisamide—CA7—Metabolism—CYP2A7—nicotine dependence	0.000464	0.00306	CbGpPWpGaD
Zonisamide—CA5B—Metabolism—CYP2A7—nicotine dependence	0.000464	0.00306	CbGpPWpGaD
Zonisamide—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.000454	0.00299	CbGpPWpGaD
Zonisamide—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000448	0.00295	CbGpPWpGaD
Zonisamide—CA12—Metabolism—CYP2A7—nicotine dependence	0.00043	0.00283	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—CHRNB2—nicotine dependence	0.000417	0.00274	CbGpPWpGaD
Zonisamide—AOX1—Disease—AKR1B10—nicotine dependence	0.000397	0.00262	CbGpPWpGaD
Zonisamide—MAOA—Neuronal System—CHRNA4—nicotine dependence	0.000378	0.00249	CbGpPWpGaD
Zonisamide—CA4—Metabolism—CYP2A7—nicotine dependence	0.000343	0.00226	CbGpPWpGaD
Zonisamide—CA2—Metabolism—CYP2A7—nicotine dependence	0.000329	0.00217	CbGpPWpGaD
Zonisamide—CA1—Metabolism—CYP2A7—nicotine dependence	0.000315	0.00208	CbGpPWpGaD
Zonisamide—AOX1—Metabolism—CYP2A7—nicotine dependence	0.000309	0.00204	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00029	0.00191	CbGpPWpGaD
Zonisamide—CA9—Metabolism—CYP2A7—nicotine dependence	0.000277	0.00183	CbGpPWpGaD
Zonisamide—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000273	0.0018	CbGpPWpGaD
Zonisamide—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000269	0.00177	CbGpPWpGaD
Zonisamide—MAOB—Metabolism—CYP2A7—nicotine dependence	0.000261	0.00172	CbGpPWpGaD
Zonisamide—MAOA—Metabolism—CYP2A7—nicotine dependence	0.000164	0.00108	CbGpPWpGaD
Zonisamide—CYP2C19—Metabolism—CYP2A7—nicotine dependence	7.76e-05	0.000511	CbGpPWpGaD
Zonisamide—CYP3A4—Metabolism—CYP2A7—nicotine dependence	4.67e-05	0.000307	CbGpPWpGaD
